TM4SF1 and prostate cancer: Originally identified as a tumor-specific antigen, TM4SF1 has been reported to be over-expressed in many epithelial cancers, such as pancreatic cancer [7], prostate cancer [17], liver cancer [5], and especially lung cancer [18].